Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ELAVL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TAF5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HADH - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRIM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLBP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTCF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SMCO4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NCAPD3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ISG20L2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ALDH3B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BLVRA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR3658 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ITGA6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HDGFRP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DNAJC6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ING1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NFATC2IP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TPR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
XK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NAA40 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on